Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand

Key TakeawaysBoston Scientific's second-quarter earnings and revenue got a boost from high demand for its heart devices.Sales of cardiovascular products made up more than half of the company's revenue in the period.Boston Scientific raised its full-year adjusted earnings per share (EPS) and revenue growth estimates. Boston Scientific (BSX) posted an increase in second-quarter earnings and sales on the back of growing demand for its heart devices. The medical device maker recorded adjusted earnings per share ...